Discovery of an imidazopyridine-containing 1,4-benzodiazepine nonpeptide vitronectin receptor (alpha v beta 3) antagonist with efficacy in a restenosis model

Bioorg Med Chem Lett. 1998 Nov 17;8(22):3171-6. doi: 10.1016/s0960-894x(98)00556-3.

Abstract

In the 3-oxo-1,4-benzodiazepine-2-acetic acid series of vitronectin receptor (alpha v beta 3) antagonists, a compound containing an imidazopyridine arginine mimetic was discovered which had sufficient potency and i.v. pharmacokinetics for demonstration of efficacy in a rat restenosis model.

MeSH terms

  • Angioplasty, Balloon, Coronary / adverse effects*
  • Animals
  • Benzodiazepines / therapeutic use*
  • Coronary Disease / drug therapy*
  • Disease Models, Animal
  • Imidazoles / therapeutic use*
  • Pyridines / therapeutic use*
  • Rats
  • Receptors, Vitronectin / antagonists & inhibitors*

Substances

  • Imidazoles
  • Pyridines
  • Receptors, Vitronectin
  • Benzodiazepines